RxLogix Corporation Email Format

Software DevelopmentFlorida, United States501-1000 Employees

RxLogix Corporation provides end-to-end pharmacovigilance software and services to support drug safety operations. Its PV Surveillance Suite is a modular platform designed for comprehensive safety data handling, including reporting, signal detection, analytics, and evaluation, and it has been selected by the FDA to replace its legacy FAERS signaling system.
Based in Aventura, Florida, the company serves pharmacovigilance and risk management professionals across the pharmaceutical sector, aiming to improve compliance, productivity, and quality in the drug safety value chain. RxLogix has engaged in regulatory collaborations, including a 2023 agreement with the European Medicines Agency to begin roll-out of the Reporting, Signal and Safety Analytics Platform. In April 2026, the company launched PVOne.AI, the fourth generation of its platform, introducing Agentic AI capabilities to enhance intelligent automation and decision support in pharmacovigilance.

Sign up for free to view info

Company overview Employee directory